Clinical Diagnostics

---

Our clinical diagnostic products focus on pathogenic bacteria detection. The tests are based on the polymerase chain reaction (PCR) and allow in vitro tests for the qualitative and quantitative diagnosis of bacteria in various clinical materials.

In many clinical settings, accurate and rapid diagnostic is important for an efficient patient management. Diagnosis of acute infections is usually based on culture and serology, known to be difficult by means of insensitivity, delayed detection and poor specificity.

By utilising the highly-sensitive PCR technology and their unique features, all these drawbacks can be avoided and efficient testing becomes available. Direct testing with the PCR detection kits is very rapid, certain and very effective. Detailed clinical studies confirm the high specificity and sensitivity of these tests, permitting early identification of clinically significant infections. By using the supplied internal control, false-negative results (due to inhibition of the reaction by the sample matrix) can be excluded individually for each sample.

In-vitro -diagnosis of Mycoplasma pneumoniae

Venor^®Mp detection of M. pneumoniae for conventional PCR

Venor^®Mp-QP detection of M. pneumoniae for real-time applications

In-vitro -diagnosis of Legionella species/pneumophila

Onar^®Ls and Onar^®Ls-QP detection of Legionella species for conventional and real-time PCR

Onar^®Lp-QP detection of L. pneumophila for real-time applications

In-vitro -diagnosis of Methicillin-resistant Staphylococcus aureus

NEW: Onar^®MRSA Screen Diagnostic Kit

In-vitro -diagnosis of Treponema pallidum

NEW: Onar^®Tp Screen Diagnostic Kit

Additionally we offer:

• Genomic DNA Extracts
• DNA-Quantification Standards (CE-marked)